leisure time -WSS

leisure time

author：leisure time 2025-09-28 00:48:14 - browse：82

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Will General Catalyst be the first of many hospital takeovers?

focus

WSS

Chamber of Commerce, DOJ clash in court over drug prices

STAT Executive Editor Rick Berke on STAT's 8th birthday

FDA approves potent Eli Lilly obesity drug, Zepbound

Ambulance rides for just $100? Advisers want major billing fixes

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

More doctors should go into startup world

focus

leisure time

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Just how powerful is the placebo effect?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

White House Covid adviser calls on docs to combat misinformation

In age of alternative facts, a scholarly course on calling out crap

Removing probiotics from the NICU could threaten preemies' health

How one medical school became remarkably diverse

Covid’s new normal has set in amid another rise in cases

After affirmative action ruling, medical educators look to 'holistic review'

People with substance use disorder deserve online privacy

entertainment

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

HPV cancer vaccine study demonstrates efficacy

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Sanofi CEO defends move to abandon profit guidance, boost research

Free Covid tests will again be offered to all U.S. households

The new shift in health care is toward less care

hotspot

focus

Wikipedia

focus